DK3831385T3 - Mandelatsalte af pirlindol-enantiomerer til anvendelse i medicin - Google Patents

Mandelatsalte af pirlindol-enantiomerer til anvendelse i medicin Download PDF

Info

Publication number
DK3831385T3
DK3831385T3 DK20198230.3T DK20198230T DK3831385T3 DK 3831385 T3 DK3831385 T3 DK 3831385T3 DK 20198230 T DK20198230 T DK 20198230T DK 3831385 T3 DK3831385 T3 DK 3831385T3
Authority
DK
Denmark
Prior art keywords
medicine
mandelate salts
pirlindole enantiomer
pirlindole
enantiomer
Prior art date
Application number
DK20198230.3T
Other languages
English (en)
Inventor
Filipe Augusto Eugénio Pardal
Pedroso Pedro Filipe Eufrásio
Pecorelli Susana Marques Almeida
Caixado Carlos Alberto Casimiro
Ana Sofia Da Conceição Lopes
João Carlos Ramos Damil
Oliveira Santos Pedro Paulo De Lacerda E
Ferreira Ana Lúcia Almeida
Original Assignee
Tecnimede Sociedade Tecnico Medicinal S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Sociedade Tecnico Medicinal S filed Critical Tecnimede Sociedade Tecnico Medicinal S
Application granted granted Critical
Publication of DK3831385T3 publication Critical patent/DK3831385T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995Pyrazines or piperazines forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK20198230.3T 2014-05-09 2014-05-09 Mandelatsalte af pirlindol-enantiomerer til anvendelse i medicin DK3831385T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/PT2014/000026 WO2015171002A1 (en) 2014-05-09 2014-05-09 Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine
EP14726441.0A EP3139926A1 (en) 2014-05-09 2014-05-09 Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine
EP20198230.3A EP3831385B1 (en) 2014-05-09 2014-05-09 Mandelate salts of pirlindole enantiomers for use in medicine

Publications (1)

Publication Number Publication Date
DK3831385T3 true DK3831385T3 (da) 2024-08-26

Family

ID=50819928

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20198230.3T DK3831385T3 (da) 2014-05-09 2014-05-09 Mandelatsalte af pirlindol-enantiomerer til anvendelse i medicin

Country Status (29)

Country Link
US (1) US10226460B2 (da)
EP (2) EP3139926A1 (da)
JP (1) JP6400121B2 (da)
KR (1) KR102276281B1 (da)
CN (1) CN106413713B (da)
AU (1) AU2014393487B2 (da)
CA (1) CA2948595C (da)
DK (1) DK3831385T3 (da)
EC (1) ECSP16086196A (da)
ES (1) ES2988983T3 (da)
FI (1) FI3831385T3 (da)
HR (1) HRP20241165T1 (da)
HU (1) HUE068011T2 (da)
IL (1) IL248852B (da)
LT (1) LT3831385T (da)
MA (1) MA39450B2 (da)
MX (1) MX373227B (da)
NZ (1) NZ726127A (da)
PH (1) PH12016502235A1 (da)
PL (1) PL3831385T3 (da)
PT (1) PT3831385T (da)
RS (1) RS65918B1 (da)
RU (1) RU2706688C2 (da)
SA (1) SA516380258B1 (da)
SI (1) SI3831385T1 (da)
SM (1) SMT202400359T1 (da)
TN (1) TN2016000495A1 (da)
UA (1) UA118587C2 (da)
WO (1) WO2015171002A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102298676B1 (ko) * 2014-05-09 2021-09-07 테크니메데 소시에다데 테크니코-메디시날 에스.에이. 의약으로서 사용되기 위한 (s)-펄린돌 및 약학적으로 허용 가능한 그의 염
TN2016000497A1 (en) 2014-05-09 2018-04-04 Tecnimede Sociedade Tecnico Medicinal S (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
EP3392251A1 (en) * 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of pirlindole enantiomers and its salts
EP3392250A1 (en) * 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK170473B1 (da) * 1985-06-20 1995-09-11 Daiichi Seiyaku Co S(-)-pyridobenzoxazinforbindelser
EP1558231A4 (en) * 2002-10-03 2010-09-08 Cypress Bioscience Inc DOSAGE CLIMBING AND FRICTIONAL DAILY DOSE OF ANTIDEPRESSANTS TO TREAT NEUROLOGICAL DISORDERS
EP1688161A1 (en) * 2004-11-02 2006-08-09 Switch Biotech Aktiengesellschaft Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
US20110268699A1 (en) * 2008-12-11 2011-11-03 Biovista, Inc. Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
US20150250808A1 (en) * 2012-10-15 2015-09-10 Vojo P. Deretic Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
JP6516769B2 (ja) * 2014-05-09 2019-05-22 テクニメデ ソシエダーデ テクニコ−メディシナル エス.アー. 光学活性ピルリンドールエナンチオマーおよびその塩を得るための方法
KR102298676B1 (ko) * 2014-05-09 2021-09-07 테크니메데 소시에다데 테크니코-메디시날 에스.에이. 의약으로서 사용되기 위한 (s)-펄린돌 및 약학적으로 허용 가능한 그의 염
TN2016000497A1 (en) * 2014-05-09 2018-04-04 Tecnimede Sociedade Tecnico Medicinal S (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine

Also Published As

Publication number Publication date
SA516380258B1 (ar) 2019-11-04
PH12016502235A1 (en) 2017-01-09
SI3831385T1 (sl) 2024-11-29
US20170143710A1 (en) 2017-05-25
SMT202400359T1 (it) 2024-11-15
ES2988983T3 (es) 2024-11-22
CA2948595A1 (en) 2015-11-12
MX373227B (es) 2020-04-21
EP3139926A1 (en) 2017-03-15
TN2016000495A1 (en) 2018-04-04
EP3831385B1 (en) 2024-07-10
CA2948595C (en) 2021-07-13
EP3831385A1 (en) 2021-06-09
KR20170002433A (ko) 2017-01-06
PT3831385T (pt) 2024-09-24
MA39450B2 (fr) 2021-10-29
AU2014393487A1 (en) 2016-11-24
JP6400121B2 (ja) 2018-10-03
IL248852B (en) 2020-05-31
HUE068011T2 (hu) 2024-12-28
AU2014393487B2 (en) 2020-01-02
LT3831385T (lt) 2024-09-10
US10226460B2 (en) 2019-03-12
RU2016148174A (ru) 2018-06-14
WO2015171002A1 (en) 2015-11-12
CN106413713A (zh) 2017-02-15
MA39450A1 (fr) 2017-08-31
PL3831385T3 (pl) 2024-10-14
FI3831385T3 (fi) 2024-09-04
NZ726127A (en) 2019-03-29
JP2017514882A (ja) 2017-06-08
MX2016014704A (es) 2017-05-23
RU2706688C2 (ru) 2019-11-20
IL248852A0 (en) 2017-01-31
CN106413713B (zh) 2020-07-14
HRP20241165T1 (hr) 2024-11-22
KR102276281B1 (ko) 2021-07-13
ECSP16086196A (es) 2017-02-24
RU2016148174A3 (da) 2018-06-14
RS65918B1 (sr) 2024-10-31
UA118587C2 (uk) 2019-02-11

Similar Documents

Publication Publication Date Title
DK3125883T3 (da) Indolderivater til anvendelse i medicin
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
PT3094728T (pt) Desenho quiral
DK3851537T5 (da) Behandling af hyperbilirubinæmi
DK3204398T3 (da) Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer
DK3302519T3 (da) Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom
DK3149129T3 (da) Anvendelse af imidazolholdige kvaternære ammoniumsalte
DK3236960T3 (da) Fluralaner til anvendelse i behandling af demodicose
HUE050779T2 (hu) Folyékony gyógyszerészeti készítmény
DK3164394T3 (da) Gls1-inhibitorer til behandling af sygdomme
HUE043624T2 (hu) Trifluormetil-alkoholok ROR-gamma-t modulátoraiként
HRP20190583T1 (hr) Postupci za pripremu spoja diariltiohidantoina
DK3125874T3 (da) Et terapeutisk middel til anvendelse i behandlingen af infektioner
DK3151814T3 (da) Behandling af en hudlæsion
DK3203835T3 (da) Fremgangsmåde til hypotermisk lagring af placentavæv
DK3831385T3 (da) Mandelatsalte af pirlindol-enantiomerer til anvendelse i medicin
DK3105485T3 (da) Tilvejebringelse af et forudbestemt fluid
DK3102264T3 (da) Kanyle til administrering af en væske
ZA201607722B (en) Process for obtaining optically active pirlindole enantiomers and salts thereof
HUE046209T2 (hu) Kompozíció porckoronggal összefüggõ fájdalom kezelésében történõ alkalmazásra
DK3200783T3 (da) Behandling af erytromelalgi
HRP20181542T1 (hr) Postupak za ekspandiranje zrelih matičnih stanica iz pune krvi
DK2965765T3 (da) Anvendelse af adelmidrol til behandling af epiteldysfunktioner
DK3677327T3 (da) Nøglesystem til sikring af korrekt anvendelse af indsatse
HRP20190314T1 (hr) Set za špricu